Therefore, the expression of HER-2 is very important for judging the diagnosis and treatment of breast cancer patients, and is an important predictor of the effect of chemotherapy and endocrine therapy in breast cancer patients. The gene discussed is ERBB2; the disease is breast carcinoma.